IP Library Granted Patent US 7,718,692
Granted Patent B2
US 7,718,692 · App. 10/778,980 · Granted May 18, 2010

Hetero-substituted acetanilide derivatives as analgesic agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,718,692
App. No.
10/778,980
Granted
May 18, 2010
Kind
B2
Abstract

Hetero-substituted acetanilide derivatives are disclosed as analgesic agents. The compounds of the invention are useful in methods for treating a disease or condition in a mammal characterized by pain and/or fever.

Claims (15)

1. A composition comprising compounds of formula (I):

wherein R 3 is hydrogen and R 1 and R 2 taken together form an optionally substituted pyrrole; tautomers, or pharmaceutically acceptable salts thereof.

2. A composition comprising a compound selected from the group consisting of:

1H-pyrrole-2-carboxylic acid (4-hydroxy-phenyl)-amide;

and tautomers, or pharmaceutically acceptable salts thereof.

3. A compounds of formula (I):

wherein R 3 is hydrogen and R 1 and R 2 taken together form an optionally substituted pyrrole, tautomers, or pharmaceutically acceptable salts thereof.

4. A compound selected from the group consisting of:

1H-pyrrole-2-carboxylic acid (4-hydroxy-phenyl)-amide;

and tautomers, or pharmaceutically acceptable salts thereof.

5. A method of controlling pain or fever in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound of formula (I):

wherein R 3 is hydrogen and R 1 and R 2 taken together form an optionally substituted pyrrole, tautomers, or pharmaceutically acceptable salts thereof.

6. A method of controlling pain or fever in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:

1H-pyrrole-2-carboxylic acid (4-hydroxy-phenyl)-amide;

and tautomers, or pharmaceutically acceptable salts thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: CARSON, JOHN R.; MCNALLY, JAMES J.
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 048168/0296 →
Continuity (1)
Related Publication 20050182108A1 · Aug 18, 2005